SCHEMBL23748393

SCHEMBL23748393

C=C[C@@H](CC(C)C)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1190713 0.79
SCHEMBL20739377 0.73 NAALAD2 (0.38)
SCHEMBL14877283 0.72
SCHEMBL23748014 0.68
SCHEMBL13147633 0.67
SCHEMBL1991395 0.67 ALDH1A1 (0.37)
SCHEMBL12868464 0.67 ALDH1A1 (0.37)
SCHEMBL9355281 0.67
SCHEMBL24612534 0.67
SCHEMBL1189982 0.67 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135758-A1 ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2023-05-04 US disclosed
US-20230135758-A1 ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2023-05-04 US disclosed
WO-2021158899-A1 ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-12 WO disclosed